These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 21633595)

  • 41. Silybin-Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress.
    Federico A; Dallio M; DI Fabio G; Zarrelli A; Zappavigna S; Stiuso P; Tuccillo C; Caraglia M; Loguercio C
    In Vivo; 2015; 29(5):569-75. PubMed ID: 26359416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats.
    El-Gazayerly ON; Makhlouf AI; Soelm AM; Mohmoud MA
    J Microencapsul; 2014; 31(1):23-30. PubMed ID: 23808477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phytosome-nanosuspensions for silybin-phospholipid complex with increased bioavailability and hepatoprotection efficacy.
    Chi C; Zhang C; Liu Y; Nie H; Zhou J; Ding Y
    Eur J Pharm Sci; 2020 Mar; 144():105212. PubMed ID: 31923602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation.
    Tsai MJ; Liao JF; Lin DY; Huang MC; Liou DY; Yang HC; Lee HJ; Chen YT; Chi CW; Huang WC; Cheng H
    Neurochem Int; 2010 Dec; 57(8):867-75. PubMed ID: 20868716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silychristin: Skeletal Alterations and Biological Activities.
    Biedermann D; Buchta M; Holečková V; Sedlák D; Valentová K; Cvačka J; Bednárová L; Křenková A; Kuzma M; Škuta C; Peikerová Ž; Bartůněk P; Křen V
    J Nat Prod; 2016 Dec; 79(12):3086-3092. PubMed ID: 28006905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
    Bijak M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism-based inhibitory and peroxisome proliferator-activated receptor α-dependent modulating effects of silybin on principal hepatic drug-metabolizing enzymes.
    Wang H; Yan T; Xie Y; Zhao M; Che Y; Zhang J; Liu H; Cao L; Cheng X; Xie Y; Li F; Qi Q; Wang G; Hao H
    Drug Metab Dispos; 2015 Apr; 43(4):444-54. PubMed ID: 25587127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016.
    Carini R; Comoglio A; Albano E; Poli G
    Biochem Pharmacol; 1992 May; 43(10):2111-5. PubMed ID: 1599497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effect of silybin on pharmacokinetics of imatinib in vivo and in vitro.
    Wang L; Wang Z; Xia MM; Wang YY; Wang HY; Hu GX
    Can J Physiol Pharmacol; 2014 Nov; 92(11):961-4. PubMed ID: 25365188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Free Radical Scavenging and Antioxidant Activities of Silymarin Components.
    Anthony KP; Saleh MA
    Antioxidants (Basel); 2013 Dec; 2(4):398-407. PubMed ID: 26784472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor.
    Gu M; Zhao P; Huang J; Zhao Y; Wang Y; Li Y; Li Y; Fan S; Ma YM; Tong Q; Yang L; Ji G; Huang C
    Front Pharmacol; 2016; 7():345. PubMed ID: 27733832
    [No Abstract]   [Full Text] [Related]  

  • 52. Modulatory effects of curcumin, silybin-phytosome and alpha-R-lipoic acid against thioacetamide-induced liver cirrhosis in rats.
    Ali SO; Darwish HA; Ismail NA
    Chem Biol Interact; 2014 Jun; 216():26-33. PubMed ID: 24704557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silymarin for HCV infection.
    Polyak SJ; Oberlies NH; Pécheur EI; Dahari H; Ferenci P; Pawlotsky JM
    Antivir Ther; 2013; 18(2):141-7. PubMed ID: 23011959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in pharmacological studies of silymarin.
    Rui YC
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():79-85. PubMed ID: 1842018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in Mice.
    Šuk J; Jašprová J; Biedermann D; Petrásková L; Valentová K; Křen V; Muchová L; Vítek L
    Oxid Med Cell Longev; 2019; 2019():6026902. PubMed ID: 30891115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective effect of the flavonoid silybin dihemisuccinate on the toxicity of phenylhydrazine on rat liver.
    Valenzuela A; Guerra R
    FEBS Lett; 1985 Feb; 181(2):291-4. PubMed ID: 3972111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
    Flaig TW; Gustafson DL; Su LJ; Zirrolli JA; Crighton F; Harrison GS; Pierson AS; Agarwal R; Glodé LM
    Invest New Drugs; 2007 Apr; 25(2):139-46. PubMed ID: 17077998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C.
    Hawke RL; Schrieber SJ; Soule TA; Wen Z; Smith PC; Reddy KR; Wahed AS; Belle SH; Afdhal NH; Navarro VJ; Berman J; Liu QY; Doo E; Fried MW;
    J Clin Pharmacol; 2010 Apr; 50(4):434-49. PubMed ID: 19841158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significantly greater antioxidant anticancer activities of 2,3-dehydrosilybin than silybin.
    Huber A; Thongphasuk P; Erben G; Lehmann WD; Tuma S; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2008 May; 1780(5):837-47. PubMed ID: 18222181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data.
    Ghodousi M; Karbasforooshan H; Arabi L; Elyasi S
    Eur J Clin Pharmacol; 2023 Jan; 79(1):15-38. PubMed ID: 36450892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.